img

Global Genome Engineering Editing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Genome Engineering Editing Market Research Report 2024

According to MRA Research’s new survey, global Genome Engineering Editing market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Genome Engineering Editing market research.
Genome engineering editing refers to the use of tools such as CRISPR-Cas9 to precisely edit and modify the genome of an organism to achieve specific gene improvement and functional regulation. With the development of genome engineering editing technology, the future trend is to continuously improve and enhance the accuracy and efficiency of editing technology. This includes improving the specificity and accuracy of the CRISPR-Cas9 system, reducing the incidence of non-specific splicing events, and increasing editing efficiency and success.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Genome Engineering Editing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Segment by Type
Homologous Recombination
Meganuclease

Segment by Application


Agriculture
Medical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Genome Engineering Editing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Engineering Editing Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 Homologous Recombination
1.2.3 Meganuclease
1.3 Market by Application
1.3.1 Global Genome Engineering Editing Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Agriculture
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Engineering Editing Market Perspective (2018-2033)
2.2 Genome Engineering Editing Growth Trends by Region
2.2.1 Global Genome Engineering Editing Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Genome Engineering Editing Historic Market Size by Region (2018-2023)
2.2.3 Genome Engineering Editing Forecasted Market Size by Region (2024-2033)
2.3 Genome Engineering Editing Market Dynamics
2.3.1 Genome Engineering Editing Industry Trends
2.3.2 Genome Engineering Editing Market Drivers
2.3.3 Genome Engineering Editing Market Challenges
2.3.4 Genome Engineering Editing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Engineering Editing Players by Revenue
3.1.1 Global Top Genome Engineering Editing Players by Revenue (2018-2023)
3.1.2 Global Genome Engineering Editing Revenue Market Share by Players (2018-2023)
3.2 Global Genome Engineering Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Engineering Editing Revenue
3.4 Global Genome Engineering Editing Market Concentration Ratio
3.4.1 Global Genome Engineering Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Engineering Editing Revenue in 2023
3.5 Genome Engineering Editing Key Players Head office and Area Served
3.6 Key Players Genome Engineering Editing Product Solution and Service
3.7 Date of Enter into Genome Engineering Editing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Engineering Editing Breakdown Data by Type
4.1 Global Genome Engineering Editing Historic Market Size by Type (2018-2023)
4.2 Global Genome Engineering Editing Forecasted Market Size by Type (2024-2033)
5 Genome Engineering Editing Breakdown Data by Application
5.1 Global Genome Engineering Editing Historic Market Size by Application (2018-2023)
5.2 Global Genome Engineering Editing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Genome Engineering Editing Market Size (2018-2033)
6.2 North America Genome Engineering Editing Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America Genome Engineering Editing Market Size by Country (2018-2023)
6.4 North America Genome Engineering Editing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Engineering Editing Market Size (2018-2033)
7.2 Europe Genome Engineering Editing Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe Genome Engineering Editing Market Size by Country (2018-2023)
7.4 Europe Genome Engineering Editing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Engineering Editing Market Size (2018-2033)
8.2 Asia-Pacific Genome Engineering Editing Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific Genome Engineering Editing Market Size by Region (2018-2023)
8.4 Asia-Pacific Genome Engineering Editing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Engineering Editing Market Size (2018-2033)
9.2 Latin America Genome Engineering Editing Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America Genome Engineering Editing Market Size by Country (2018-2023)
9.4 Latin America Genome Engineering Editing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Engineering Editing Market Size (2018-2033)
10.2 Middle East & Africa Genome Engineering Editing Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa Genome Engineering Editing Market Size by Country (2018-2023)
10.4 Middle East & Africa Genome Engineering Editing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genome Engineering Editing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genome Engineering Editing Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 SIGMA ALDRICH
11.2.1 SIGMA ALDRICH Company Detail
11.2.2 SIGMA ALDRICH Business Overview
11.2.3 SIGMA ALDRICH Genome Engineering Editing Introduction
11.2.4 SIGMA ALDRICH Revenue in Genome Engineering Editing Business (2018-2023)
11.2.5 SIGMA ALDRICH Recent Development
11.3 Dharmacon
11.3.1 Dharmacon Company Detail
11.3.2 Dharmacon Business Overview
11.3.3 Dharmacon Genome Engineering Editing Introduction
11.3.4 Dharmacon Revenue in Genome Engineering Editing Business (2018-2023)
11.3.5 Dharmacon Recent Development
11.4 Cellectics
11.4.1 Cellectics Company Detail
11.4.2 Cellectics Business Overview
11.4.3 Cellectics Genome Engineering Editing Introduction
11.4.4 Cellectics Revenue in Genome Engineering Editing Business (2018-2023)
11.4.5 Cellectics Recent Development
11.5 CRISPR Therapeutics
11.5.1 CRISPR Therapeutics Company Detail
11.5.2 CRISPR Therapeutics Business Overview
11.5.3 CRISPR Therapeutics Genome Engineering Editing Introduction
11.5.4 CRISPR Therapeutics Revenue in Genome Engineering Editing Business (2018-2023)
11.5.5 CRISPR Therapeutics Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Genome Engineering Editing Introduction
11.6.4 AstraZeneca Revenue in Genome Engineering Editing Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Bio Rad
11.7.1 Bio Rad Company Detail
11.7.2 Bio Rad Business Overview
11.7.3 Bio Rad Genome Engineering Editing Introduction
11.7.4 Bio Rad Revenue in Genome Engineering Editing Business (2018-2023)
11.7.5 Bio Rad Recent Development
11.8 Allele Biotech
11.8.1 Allele Biotech Company Detail
11.8.2 Allele Biotech Business Overview
11.8.3 Allele Biotech Genome Engineering Editing Introduction
11.8.4 Allele Biotech Revenue in Genome Engineering Editing Business (2018-2023)
11.8.5 Allele Biotech Recent Development
11.9 Recombinetics
11.9.1 Recombinetics Company Detail
11.9.2 Recombinetics Business Overview
11.9.3 Recombinetics Genome Engineering Editing Introduction
11.9.4 Recombinetics Revenue in Genome Engineering Editing Business (2018-2023)
11.9.5 Recombinetics Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Genome Engineering Editing Introduction
11.10.4 Lonza Revenue in Genome Engineering Editing Business (2018-2023)
11.10.5 Lonza Recent Development
11.11 GE Healthcare
11.11.1 GE Healthcare Company Detail
11.11.2 GE Healthcare Business Overview
11.11.3 GE Healthcare Genome Engineering Editing Introduction
11.11.4 GE Healthcare Revenue in Genome Engineering Editing Business (2018-2023)
11.11.5 GE Healthcare Recent Development
11.12 Editas Medicine
11.12.1 Editas Medicine Company Detail
11.12.2 Editas Medicine Business Overview
11.12.3 Editas Medicine Genome Engineering Editing Introduction
11.12.4 Editas Medicine Revenue in Genome Engineering Editing Business (2018-2023)
11.12.5 Editas Medicine Recent Development
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Detail
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Genome Engineering Editing Introduction
11.13.4 Agilent Technologies Revenue in Genome Engineering Editing Business (2018-2023)
11.13.5 Agilent Technologies Recent Development
11.14 QIAGEN NV
11.14.1 QIAGEN NV Company Detail
11.14.2 QIAGEN NV Business Overview
11.14.3 QIAGEN NV Genome Engineering Editing Introduction
11.14.4 QIAGEN NV Revenue in Genome Engineering Editing Business (2018-2023)
11.14.5 QIAGEN NV Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Genome Engineering Editing Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of Homologous Recombination
Table 3. Key Players of Meganuclease
Table 4. Global Genome Engineering Editing Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 5. Global Genome Engineering Editing Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 6. Global Genome Engineering Editing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Genome Engineering Editing Market Share by Region (2018-2023)
Table 8. Global Genome Engineering Editing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Genome Engineering Editing Market Share by Region (2024-2033)
Table 10. Genome Engineering Editing Market Trends
Table 11. Genome Engineering Editing Market Drivers
Table 12. Genome Engineering Editing Market Challenges
Table 13. Genome Engineering Editing Market Restraints
Table 14. Global Genome Engineering Editing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Genome Engineering Editing Market Share by Players (2018-2023)
Table 16. Global Top Genome Engineering Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Engineering Editing as of 2023)
Table 17. Ranking of Global Top Genome Engineering Editing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Genome Engineering Editing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Genome Engineering Editing Product Solution and Service
Table 21. Date of Enter into Genome Engineering Editing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Genome Engineering Editing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Genome Engineering Editing Revenue Market Share by Type (2018-2023)
Table 25. Global Genome Engineering Editing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Genome Engineering Editing Revenue Market Share by Type (2024-2033)
Table 27. Global Genome Engineering Editing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Genome Engineering Editing Revenue Market Share by Application (2018-2023)
Table 29. Global Genome Engineering Editing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Genome Engineering Editing Revenue Market Share by Application (2024-2033)
Table 31. North America Genome Engineering Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 32. North America Genome Engineering Editing Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Genome Engineering Editing Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Genome Engineering Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 35. Europe Genome Engineering Editing Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Genome Engineering Editing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Genome Engineering Editing Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 38. Asia-Pacific Genome Engineering Editing Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Genome Engineering Editing Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Genome Engineering Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 41. Latin America Genome Engineering Editing Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Genome Engineering Editing Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Genome Engineering Editing Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. Middle East & Africa Genome Engineering Editing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Genome Engineering Editing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Detail
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific Genome Engineering Editing Product
Table 49. Thermo Fisher Scientific Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. SIGMA ALDRICH Company Detail
Table 52. SIGMA ALDRICH Business Overview
Table 53. SIGMA ALDRICH Genome Engineering Editing Product
Table 54. SIGMA ALDRICH Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 55. SIGMA ALDRICH Recent Development
Table 56. Dharmacon Company Detail
Table 57. Dharmacon Business Overview
Table 58. Dharmacon Genome Engineering Editing Product
Table 59. Dharmacon Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 60. Dharmacon Recent Development
Table 61. Cellectics Company Detail
Table 62. Cellectics Business Overview
Table 63. Cellectics Genome Engineering Editing Product
Table 64. Cellectics Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 65. Cellectics Recent Development
Table 66. CRISPR Therapeutics Company Detail
Table 67. CRISPR Therapeutics Business Overview
Table 68. CRISPR Therapeutics Genome Engineering Editing Product
Table 69. CRISPR Therapeutics Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 70. CRISPR Therapeutics Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Genome Engineering Editing Product
Table 74. AstraZeneca Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Bio Rad Company Detail
Table 77. Bio Rad Business Overview
Table 78. Bio Rad Genome Engineering Editing Product
Table 79. Bio Rad Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 80. Bio Rad Recent Development
Table 81. Allele Biotech Company Detail
Table 82. Allele Biotech Business Overview
Table 83. Allele Biotech Genome Engineering Editing Product
Table 84. Allele Biotech Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 85. Allele Biotech Recent Development
Table 86. Recombinetics Company Detail
Table 87. Recombinetics Business Overview
Table 88. Recombinetics Genome Engineering Editing Product
Table 89. Recombinetics Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 90. Recombinetics Recent Development
Table 91. Lonza Company Detail
Table 92. Lonza Business Overview
Table 93. Lonza Genome Engineering Editing Product
Table 94. Lonza Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 95. Lonza Recent Development
Table 96. GE Healthcare Company Detail
Table 97. GE Healthcare Business Overview
Table 98. GE Healthcare Genome Engineering Editing Product
Table 99. GE Healthcare Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 100. GE Healthcare Recent Development
Table 101. Editas Medicine Company Detail
Table 102. Editas Medicine Business Overview
Table 103. Editas Medicine Genome Engineering Editing Product
Table 104. Editas Medicine Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 105. Editas Medicine Recent Development
Table 106. Agilent Technologies Company Detail
Table 107. Agilent Technologies Business Overview
Table 108. Agilent Technologies Genome Engineering Editing Product
Table 109. Agilent Technologies Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 110. Agilent Technologies Recent Development
Table 111. QIAGEN NV Company Detail
Table 112. QIAGEN NV Business Overview
Table 113. QIAGEN NV Genome Engineering Editing Product
Table 114. QIAGEN NV Revenue in Genome Engineering Editing Business (2018-2023) & (US$ Million)
Table 115. QIAGEN NV Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genome Engineering Editing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Genome Engineering Editing Market Share by Type: 2023 VS 2033
Figure 3. Homologous Recombination Features
Figure 4. Meganuclease Features
Figure 5. Global Genome Engineering Editing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Genome Engineering Editing Market Share by Application: 2023 VS 2033
Figure 7. Agriculture Case Studies
Figure 8. Medical Case Studies
Figure 9. Others Case Studies
Figure 10. Genome Engineering Editing Report Years Considered
Figure 11. Global Genome Engineering Editing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Genome Engineering Editing Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 13. Global Genome Engineering Editing Market Share by Region: 2023 VS 2033
Figure 14. Global Genome Engineering Editing Market Share by Players in 2023
Figure 15. Global Top Genome Engineering Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Engineering Editing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Genome Engineering Editing Revenue in 2023
Figure 17. North America Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Genome Engineering Editing Market Share by Country (2018-2033)
Figure 19. United States Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Genome Engineering Editing Market Share by Country (2018-2033)
Figure 23. Germany Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Genome Engineering Editing Market Share by Region (2018-2033)
Figure 31. China Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Genome Engineering Editing Market Share by Country (2018-2033)
Figure 39. Mexico Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Genome Engineering Editing Market Share by Country (2018-2033)
Figure 43. Turkey Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Genome Engineering Editing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 46. SIGMA ALDRICH Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 47. Dharmacon Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 48. Cellectics Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 49. CRISPR Therapeutics Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 51. Bio Rad Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 52. Allele Biotech Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 53. Recombinetics Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 54. Lonza Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 55. GE Healthcare Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 56. Editas Medicine Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 57. Agilent Technologies Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 58. QIAGEN NV Revenue Growth Rate in Genome Engineering Editing Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed